“HYPERTONIC SALINE SOLUTION IN CHILDREN WITH ADENOIDAL HYPERYTROPHY: PRELIMINARY EVIDENCE”
09-10-2007 on EUROPEAN JOURNAL OF INFLAMMATION
G. CIPRANDI, A.VARRICCHIO,M.CAPASSO,A.M.VARRICCHIO,A.DE LUCIA,E.ASCIONE,F.AVVISATI, M.DI GIOACCHINO and U. BARILLARI
Adenoidal hypertrophy (AH) is a frequent problem in children. A preliminary study evidenced that intranasal hypertonic solutions may exert an anti-inflammatory activity. The aim of the study is to evaluate the effect of intranasal hypertonic or isotonic solutions in children affected with AH. For this purpose, 78 children with AH were evaluated in a randomised and controlled study. Inclusion criteria for the study required that each patient had to have a III or IV degree of AH on the initial endoscopic examination. Children were treated with intranasal hypertonic or isotonic saline solution for 8 weeks. After treatment, endoscopy was performed to evaluate AH degree. Hypertonic treatment was associated with significant (p<0.05) reduction of AH degree. There was a consistent reduction of children with III degree of AH. No adverse events were reported. This preliminary study demonstrates that an 8-week treatment with intranasal hypertonic solution is associated with significant reduction of AH. Therefore, this study evidences that hypertonic solution may exert an anti-inflammatory activity and is safe.
“Hypertonic saline solution in children with adenoidal hyperytrophy: preliminary evidence”